NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/29/2023
Back to search
Official data from USPTO
ILUMYA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
08/29/2023
Trademark type
Combined
Nice classes
5
Filing date
10/12/2022
Registration date
08/29/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/29/2023
Last transaction
08/29/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/28/2018
First use in commerce
09/28/2018
Drawing code
3
Owner type
16
Owner location
Mumbai, Maharashtra, IN
Examiner
GARCIA, CLAUDIA
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of purple, blue and yellow wavy bands appearing to the left of the word "ILUMYA" in purple.
Holders and representatives
Holders
Sun Pharmaceutical Industries Limited
Representatives
Craig Kuchii SUN PHARMACEUTICAL INDUSTRIES, INC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the treatment of immunologic diseases and disordersautoimmune diseases and disorders; pharmaceutical preparations for the treatment of dermatitiseczema and psoriasis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of digestive diseases and disorderscrohn's diseaseirritable bowel syndrome; intestinal disorder medicine for the treatment of ulcerative colitis; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of cancer
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/29/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/13/2023
PUBO
PUBLISHED FOR OPPOSITION
06/13/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/24/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/28/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/28/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/08/2023
GNRT
NON-FINAL ACTION E-MAILED
04/08/2023
CNRT
NON-FINAL ACTION WRITTEN
04/08/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/04/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
03/21/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/06/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
03/06/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/06/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
03/06/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/06/2023
DOCK
ASSIGNED TO EXAMINER
02/24/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/27/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/26/2022
NWAP
NEW APPLICATION ENTERED
10/15/2022
Continuous trademark protection
Get notified about every new filing that threatens ILUMYA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.